Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Clinical pharmacokinetics of thalidomide.

Teo SK, Colburn WA, Tracewell WG, Kook KA, Stirling DI, Jaworsky MS, Scheffler MA, Thomas SD, Laskin OL.

Clin Pharmacokinet. 2004;43(5):311-27. Review.

PMID:
15080764
2.

Single-dose pharmacokinetics of lenalidomide in healthy volunteers: dose proportionality, food effect, and racial sensitivity.

Chen N, Kasserra C, Reyes J, Liu L, Lau H.

Cancer Chemother Pharmacol. 2012 Nov;70(5):717-25. doi: 10.1007/s00280-012-1966-z. Epub 2012 Sep 6.

PMID:
22955172
3.

Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.

Guo B, Wu X, Zhang Y, Shi Y, Yu J, Cao G, Zhang J.

Clin Drug Investig. 2012 Jul 1;32(7):475-86. doi: 10.2165/11632780-000000000-00000.

PMID:
22650326
4.

Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.

Scheffler MR, Colburn W, Kook KA, Thomas SD.

Clin Pharmacol Ther. 1999 May;65(5):483-90.

PMID:
10340913
5.

Clinical pharmacology of thalidomide.

Eriksson T, Björkman S, Höglund P.

Eur J Clin Pharmacol. 2001 Aug;57(5):365-76. Review.

PMID:
11599654
6.

Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.

Teo SK, Scheffler MR, Kook KA, Tracewell WG, Colburn WA, Stirling DI, Thomas SD.

Biopharm Drug Dispos. 2000 Jan;21(1):33-40.

PMID:
11038436
7.

Clinical pharmacokinetics of ranolazine.

Jerling M.

Clin Pharmacokinet. 2006;45(5):469-91. Review.

PMID:
16640453
8.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
9.

Thalidomide dose proportionality assessment following single doses to healthy subjects.

Teo SK, Scheffler MR, Kook KA, Tracewell WG, Colburn WA, Stirling DI, Thomas SD.

J Clin Pharmacol. 2001 Jun;41(6):662-7.

PMID:
11402635
10.

Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers.

Teo SK, Colburn WA, Thomas SD.

J Clin Pharmacol. 1999 Nov;39(11):1162-8.

PMID:
10579147
11.

Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.

Lecaillon JB, Kaiser G, Palmisano M, Morgan J, Della Cioppa G.

Eur J Clin Pharmacol. 1999 Apr;55(2):131-8.

PMID:
10335908
12.

Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.

Sarashina A, Sesoko S, Nakashima M, Hayashi N, Taniguchi A, Horie Y, Graefe-Mody EU, Woerle HJ, Dugi KA.

Clin Ther. 2010 Jun;32(6):1188-204. doi: 10.1016/j.clinthera.2010.06.004.

PMID:
20637971
13.

Pharmacokinetics of thalidomide in an elderly prostate cancer population.

Figg WD, Raje S, Bauer KS, Tompkins A, Venzon D, Bergan R, Chen A, Hamilton M, Pluda J, Reed E.

J Pharm Sci. 1999 Jan;88(1):121-5.

PMID:
9874712
14.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Staatz CE, Tett SE.

Clin Pharmacokinet. 2007;46(1):13-58. Review.

PMID:
17201457
15.

The clinical pharmacokinetics of levofloxacin.

Fish DN, Chow AT.

Clin Pharmacokinet. 1997 Feb;32(2):101-19. Review.

PMID:
9068926
16.

Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.

Chen TL, Vogelsang GB, Petty BG, Brundrett RB, Noe DA, Santos GW, Colvin OM.

Drug Metab Dispos. 1989 Jul-Aug;17(4):402-5.

PMID:
2571480
17.

Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study.

Chu NN, Chen WL, Xu HR, Li XN.

Clin Drug Investig. 2009;29(7):451-7. doi: 10.2165/00044011-200929070-00003.

PMID:
19499962
19.

Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.

Taylor TJ, Diringer K, Russell T, Venkatakrishnan K, Wilner K, Crownover PH, Benincosa LJ, Gibbs MA.

Clin Pharmacokinet. 2006;45(10):989-1001.

PMID:
16984212
20.

Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.

Eriksson T, Björkman S, Roth B, Fyge A, Höglund P.

Chirality. 1995;7(1):44-52.

PMID:
7702998

Supplemental Content

Support Center